ArticleBMC medical informatics and decision making2026
Construction of a predictive model for the risk of non-alcoholic fatty liver disease in patients with sleep apnea syndrome based on multiple machine learning algorithms: a multicenter study.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSleep apnea syndrome (SAS) is closely related to an increased risk of non-alcoholic fatty liver disease (NAFLD), but current clinical tools lack the integration of multidimensional data for accurate risk prediction. This study employs various machine learning algorithms to develop and validate a risk prediction model for the occurrence of NAFLD in SAS patients.
methodsThis retrospective multi-center study used data from 595 SAS patients diagnosed in 2024 at Wuxi Fifth People's Hospital (training cohort) and 372 patients from Wuxi Second People's Hospital (external validation cohort). Demographic, anthropometric, biochemical, and comorbidity data were collected. Multivariate logistic regression was used to explore the risk factors for NAFLD in SAS patients, and restricted cubic spline (RCS) non-linear trend analysis was performed on the risk factors. After preprocessing and variable selection using Boruta and LASSO regression, nine machine learning models were trained. The best-performing model was selected based on the area under the receiver operating characteristic curve (AUC) and underwent external validation.
resultsMultifactorial logistic regression analysis found that sex, obesity, hyperlipidemia, low-density lipoprotein cholesterol (LDL-C), AST to ALT ratio, uric acid, γ-glutamyltransferase (GGT), albumin, and PLT were significantly associated with the occurrence of NAFLD in SAS patients. The aspartate aminotransferase to alanine aminotransferase ratio (AST to ALT ratio), GGT, albumin, and platelet count (PLT) exhibited a non-linear relationship with the occurrence of NAFLD in SAS patients. Among the 9 machine learning models, logistic regression was the best model (AUC = 0.752, 95% CI: 0.654-0.850). Key predictive features included LDL-C, hyperlipidemia, high-density lipoprotein cholesterol (HDL-C), AST/ALT, and GGT. SHAP analysis showed that elevated LDL-C, hyperlipidemia, and GGT increased the risk of NAFLD, while higher HDL-C levels had a protective effect. The AST/ALT ratio was negatively correlated with risk.
conclusionThis study found that sex, obesity, hyperlipidemia, LDL-C, AST to ALT ratio, uric acid, GGT, albumin, and PLT were significantly associated with the occurrence of NAFLD in SAS patients. The logistic regression model established in this study effectively predicts the risk of NAFLD in SAS patients, emphasizing the core role of lipid metabolism abnormalities and markers of oxidative stress. This tool provides a practical and easily interpretable solution for early risk stratification and targeted intervention in clinical practice. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.